Chemitope Glycopeptide Inc. — Form D/A
Chemitope Glycopeptide Inc. of BROOKLYN, NY, a company, filed a Form D amendment with the SEC on 2019-03-15. The offering totals $350K, of which $200K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-03-15
- Form: D/A
- Accession: 0001714830-19-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $350K
- Amount sold: $200K
- Remaining: $150K
- Minimum investment: $25K
- Investors: 3
- Date of first sale: 2017-07-31
- Revenue range: $1 - $1,000,000
- SEC file number: 021-294747
Issuer
- Name: Chemitope Glycopeptide Inc.
- CIK: 0001714830
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 684 LINCOLN PLACE, BROOKLYN, NY, 11216
- Phone: 917-539-9263
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Baptiste Aussedat | Director | New York, NY |
| William Walkowicz | Director | Brooklyn, NY |
| Baptiste Aussedat | Executive Officer | New York, NY |
| William Walkowicz | Executive Officer | Brooklyn, NY |
Other filings by this issuer (1)
More